Stock Events

Stock Events

Bristol-Myers Squibb

$899.9

5268

-$0.1-0.01% Tuesday 18:47

Statistics

Day High

740

Day Low

740

52W High

1,255

52W Low

700

Volume

2

Avg. Volume

2

Mkt Cap

82.02B

P/E Ratio

-13.34

Dividend Yield

0.22%

Dividend

2

Upcoming

Dividends

0.22%Dividend Yield

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

Earnings

26JulConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

Next

-4.47

-2.3

-0.12

2.05

Expected EPS

1.682799

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMYMP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.

Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.

Johnson & Johnson

Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.

AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.

GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.

Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.

Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.

Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.

Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.

AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

Pharmaceuticals: Major

Health Technology

Manufacturing

Pharmaceutical Preparation Manufacturing

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Show more...

CEO

Giovanni Caforio

Country

US

ISIN

US1101222073

Listings